¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£ÇÐȸ The Liver Week 2024 Day 2 : 2024-06-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑ°£ÇÐȸ The Liver Week 2024 Day 2 : 2024-06-28
±³À°ÀÏÀÚ : 2024-06-28
±³À°Àå¼Ò : ¿öÄ¿Èú¼­¿ïÈ£ÅÚ ROOM 1~10

±³À°ÁÖÁ¦ : The Liver Week 2024 Day 2

ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ
¿¬¶ôó : 02-707-0091  

À̸ÞÀÏ : kasl@kams.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 31 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 21,000¿ø  

ºñ°í [TLW]Member-150,000/ Resident, Trainee, Fellow, Researcher, Army Doctor, Nurse, or Others-90,000/ Resident, Trainee, Army Doctor + Private Hands-On Ultrasound Course on June 27-140,000/ Non-Member, Healthcare Professional-180,000 International Delegate-USD 150 Travel Award Recipient-USD 40 [PG]Member-60,000/ Resident, Trainee, Fellow, Researcher, Army Doctor, Nurse, or Others-40,000 Non-Member, Healthcare Professional-70,000


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 09:10~09:30 Standardized and Individualized Criteria for Cessation of Antiviral Therapy in Chronic Hepatitis B Hyung Joon Yim(Korea Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 09:30~09:50 Monitoring and Prevention of Reactive and Progressive Properties of Occult Hepatitis B Virus Infection Jeong Won Jang(The Catholic Univ. of Korea)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 09:50~10:10 Precision Strategy for HCC Surveillance after Curing Hepatitis C: Debates across Guidelines Tatsuya Kanto(National Center for Global Health and Medicine, Japan)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 10:10~10:30 Experimental Drugs and Therapeutic Endpoints of Chronic Hepatitis D Maria Buti(Univ. of Barcelona, Spain)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 11:10~11:40 The Journey of a Hepatologist W. Ray Kim(Stanford Univ., USA)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 11:40~11:55 Transarterial Radioembolization versus Atezolizumab plus Bevacizumab in Hepatocellular Carcinoma with Portal Vein Thrombosis Youngsu Park(Seoul National University)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 11:55~12:10 LI-RADS imaging diagnosis of hepatocellular Carcinoma in noncirrhotic patients with chronic hepatitis C: a multicenter development and validation cohort Ha Il Kim(Hanyang University)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 12:10~12:25 Anatomical Risk Factors for Portal Vein Complications Following Right Hepatectomy in Living Donors: Analysis of Results from 4720 Cases Young-In Yoon(University of Ulsan)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 12:25~12:40 Persistent systemic inflammation is important driver of acute-on-chronic liver failure and organ failure development Do Seon Song(The Catholic University of Korea)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 13:30~13:50 Temporal and Spatial Cancer Evolution of Dysplastic Nodules in the Liver Ju Hyun Shim(Univ. of Ulsan)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 13:50~14:10 Genomic and Epigenetic Clues to Persistent Risk of HCC after Curing Hepatitis C Yujin Hoshida(Univ. of Texas Southwestern Medical Center, USA)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 14:10~14:30 Clinical and Subclinical Risk Factors of Non-Viral HCC: Is It Preventable? Do Young Kim(Yonsei Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 14:30~14:50 Guidelines and Evidence-Based Recommendations for Sequential Systemic Therapy of HCC Grace L. Su(Univ. of Michigan, USA)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 14:50~15:10 Genetic Vulnerabilities of Alcohol-Related Hepatitis and HCC in the East and West Jean-Charles Nault(Sorbonne Université, France)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 15:10~15:30 Biomarkers in Alcohol-Related Liver Diseases Pierre-Emmanuel Rautou(Université Paris-Cité, France)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 15:30~15:50 Principles of and Debates on Indication and Duration of Use of Corticosteroids in Severe Alcoholic Hepatitis Young Kul Jung(Korea Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 15:50~16:10 Optimal Timing of Liver Transplantation in Severe Alcoholic Hepatitis Julie K. Heimbach(Mayo Clinic, USA)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 16:30~16:50 Approach to Abnormal Liver Blood Tests of Inpatients and Outpatients Myeong Jun Song(The Catholic Univ. of Korea)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 16:50~17:10 Adverse Events of Systemic Therapy in HCC Patients: Assessment and Education Eun Ju Cho(Seoul National Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 17:10~17:30 Role of Artificial Intelligence to Assist Clinical Research Coordinators Hyun Suk Park(Asan Medical Center)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 1 17:30~17:50 Current Status and Prospects of Site Management Organization (SMO) in Clinical Trials Seong Jae Kim(Gyeongsang National Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 09:10~09:30 Current and Future Perspective of Spatial Omics in HCC Junil Kim(Soongsil Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 09:30~09:50 Precision Medicine for Designing Future Clinical Trials for Immuno-Oncology Treatment Sun Young Yim(Korea Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 09:50~10:10 Radiogenomics and Radiomics in Liver Cancers Hyungjin Rhee(Yonsei Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 10:10~10:30 Discovery of Blood Biomarkers for Immune-Based Treatments of HCC: Protein vs. cfDNA/snRNA Hye Won Lee(Yonsei Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 13:30~13:50 Trailblazing First-Line Therapies: Which Immuno-Oncology Therapy Would be the Best for Advanced HCC? Yong-Han Paik(Sungkyunkwan Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 13:50~14:10 Navigating the Post-Immunotherapy: Second-Line Options for HCC Masatoshi Kudo(Kindai Univ., Japan)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 14:10~14:30 Overcoming Resistance and Relapse against HCC Immunotherapy Pil Soo Sung(The Catholic Univ. of Korea)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 14:30~14:50 Predictive Biomarker Research of Combination Immunotherapy: Current Status and Future Perspectives Takahiro Kodama(Osaka Univ., Japan)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 14:50~15:10 Maximizing Indication and Safety in Living Donor Liver Transplantation for HCC Pyoung Jae Park(Korea Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 15:10~15:30 Making an Impact with Radioembolization for HCC Management Hyo-Cheol Kim(Seoul National Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 15:30~15:50 Harnessing the Power of Radiotherapies for HCC Treatment Jeong Il Yu(Sungkyunkwan Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 15:50~16:10 Evolving Strategies: Treatment Patterns of HCC from Korean Claims Data Ji Won Han(The Catholic Univ. of Korea)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 2 16:10~16:30 HCC in Korea: The Past, Present and the Future Hae Lim Lee(The Catholic Univ. of Korea)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 09:10~09:30 Attributes and Principles for Better Practice Guidelines: An Experience with KLCA-NCC Korea Practice Guidelines for HCC Joong-Won Park(Myongji Hospital, Hanyang Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 09:30~10:00 AASLD Guidelines on Clinical Assessment and Management of MASLD Rohit Loomba(Univ. of California San Diego, USA)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 10:00~10:30 EASL Guidelines on Vascular Liver Disease Pierre-Emmanuel Rautou(Université Paris-Cité, France)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 13:30~13:50 Clinical Data Based on Old NAFLD and New MASLD: Shared vs. Separated Mark Muthiah(National Univ. Hospital, Singapore)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 13:50~14:10 Diagnostic Criteria and Clinical Impact of Steatotic Liver Disease Sub-Classification Byoung Kuk Jang(Keimyung Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 14:10~14:30 Pathophysiology-Based Treatment Targets and Successful Trials in MASH Mi Na Kim(Yonsei Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 14:30~14:50 Tumor Immunity and Immunotherapeutic Susceptibility of Steatotic HCC Tetsuo Takehara(Osaka Univ., Japan)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 14:50~15:10 Different Definitions and Prognostic Stratification of Acute-on-Chronic Liver Failure Rakhi Maiwall(Institute of Liver and Biliary Sciences, India)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 15:10~15:30 Respiratory Support in Acute-on-Chronic Liver Failure Jin Won Huh(Univ. of Ulsan)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 3 15:30~15:50 Management of Organ Failure and Infection in Critically-ill Patients with Acute-on-Chronic Liver Failure Guadalupe Garcia-Tsao(Yale Univ., USA)

Åä·Ð 06¿ù 28ÀÏ ROOM 3 15:50~16:10 Panel Discussion ()

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 09:10~09:30 Patient Selection and Result for Unresectable Hepatic Metastasis from Colorectal Cancer Jongman Kim(Sungkyunkwan Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 09:30~09:50 Perihilar Cholangiocarcinoma: Current Strategy and Future Directions Julie K. Heimbach(Mayo Clinic, USA)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 09:50~10:10 The Role of Liver Transplantation for Intrahepatic Cholangiocarcinoma Ho Joong Choi(The Catholic Univ. of Korea)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 10:10~10:30 HCC with Portal Vein Tumor Thrombosis Kwangho Yang(Pusan National Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 11:40~12:10 Long-Term Follow-Up and Support Programs for Living Liver Donors in Korea YoungRok Choi(Seoul National Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 12:10~12:25 Current Status of Living Liver Donor Management at Low Volume Center Min Kyung Nam(Hanyang Univ. Seoul Hospital)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 12:25~12:40 Considerations for Liver Donor Management Ji Eun Lee(Severance Hospital)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 13:30~13:50 De Novo Malignancies: Long-Term Experience and Surveillance Strategy Woo-Hyoung Kang(Univ. of Ulsan)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 13:50~14:10 How to Deal with Chronic Disease after Liver Transplantation Jae Geun Lee(Yonsei Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 14:10~14:30 Treading a Tightrope: A Strategy that Provides Minimal Immune Suppression while Reducing Rejection and Graft Fibrosis Sang Hoon Lee(Sungkyunkwan Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 14:30~14:50 Physical Therapy and Exercise to Improve Quality of Life after Liver Transplantation Won Kim(Univ. of Ulsan)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 14:50~15:10 Seoul National University Hospital Experience Kwang-Woong Lee(Seoul National Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 15:10~15:30 Samsung Medical Center Experience Gyu-seong Choi(Sungkyunkwan Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 4 15:30~15:50 Dr. Rela Institute Experience Ashwin Rammohan(Rela Hospital, India)

Åä·Ð 06¿ù 28ÀÏ ROOM 4 15:50~16:10 Panel Discussion ()

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 5 07:30~08:00 Before and After TIPS: Practical Insights from Real-World Experience Min Kyung Park(Seoul National Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 5 08:00~08:15 Tips for Getting an Acceptance from AASLD Journals Elliot B. Tapper(Univ. of Michigan, USA)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 5 08:15~08:30 Tips for Getting an Acceptance from CMH Won Kim(Seoul National Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 5 08:30~08:45 Hepatology Editor's Picks: Noticeable Publications in 2023-2024 Yujin Hoshida(Univ. of Texas Southwestern Medical Center, USA)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 5 08:45~09:00 CMH Editor's Picks: Noticeable Publications in 2023-2024 Seung Up Kim(Yonsei Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 6 08:00~08:20 Past and Present of LI-RADS in HCC Diagnosis Sunyoung Lee(Yonsei Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 6 08:20~08:40 LI-RADS: It Is Time to Focus on Prognosis Subin Heo(Univ. of Ulsan)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 6 08:40~09:00 Future Perspectives and New Challenges in LI-RADS Bin Song(Sichuan Univ., China)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 08:00~08:25 Understanding Spatial Transcriptomics in Hepatology: From Sample Preparation to Application Kwon Joong Na(Seoul National Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 08:25~08:50 Emerging Organoid Technologies to Apply for Precision Medicine in Hepatology Myung Jin Son(Korea Research Institute of Bioscience and Biotechnology)

Åä·Ð 06¿ù 28ÀÏ ROOM 7 08:50~09:00 Discussion ()

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 09:10~09:40 Hepatocellular Carcinoma in RNA Biology Jungwook Hwang(Hanyang Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 09:40~10:05 Dysregulation of Liver Regeneration by Hepatitis B Virus Infection: Impact on Development of HCC Kyun-Hwan Kim(Sungkyunkwan Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 10:05~10:30 Modulation of Amino Acid Metabolism as a Therapeutic Target of Liver Cancer Keun-Gyu Park(Kyungpook National Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 13:30~13:50 Practical Approach for Causal Inference Danbee Kang(Sungkyunkwan Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 13:50~14:10 Advanced Survival Analysis Seo Young Park(Korea National Open Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 14:10~14:30 Development of Clinical Prediction Models Sehee Kim(Univ. of Ulsan)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 14:30~14:50 Various Model Performance Measures Seungbong Han(Korea Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 14:50~15:10 Common Data Model (CDM) for Observational Research Seng Chan You(Yonsei Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 15:10~15:30 AI's Role in Diagnosis and Prognosis Kyu-Hwan Jung(Sungkyunkwan Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 15:30~15:50 Big Data in Healthcare: Research and Applications So-Ryoung Lee(Seoul National Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 7 15:50~16:10 Guide for Radiomics Study to Clinical Researchers Hyo Jung Park(Univ. of Ulsan)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 09:10~09:20 Case Presentation 1. (Internal Medicine) Yuri Cho(National Cancer Center)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 09:20~09:30 Case Presentation 2. (Surgery) Jae Geun Lee(Yonsei Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 09:30~09:50 Endoscopic and Percutaneous Biliary Decompression Sang Hyub Lee(Seoul National Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 09:50~10:10 Transarterial Intervention Treatments Dongho Hyun(Sungkyunkwan Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 10:10~10:30 Liver Resection and Transplantation Xiao Xu(Zhejiang Univ., China)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 13:30~13:50 °£¾Ï ÀûÁ¤¼ºÆò°¡ ¹× ÇâÈÄ°úÁ¦ Nam Ryoung Kim(Health Insurance Review & Assessment Service)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 13:50~14:10 Ç×¾ÏÁ¦ ¾àÁ¦±Þ¿©±âÁØ Mi Young Kang(Health Insurance Review & Assessment Service)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 14:10~14:30 Management Model after Screening for Viral Hepatitis B and C in Korea Young Chang(Soonchunhyang Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 14:30~14:50 Local Government-Based Hepatitis C Elimination Project: Jeollanam-do Performance Report Min-Ho Shin(Chonnam National Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 14:50~15:10 Epidemiologic and Genetic Landscapes of Polycystic Liver Disease Beom Kyung Kim(Yonsei Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 15:10~15:30 Radiological Diagnosis for Cystic Liver Disease Seung Baek Hong(Pusan National Univ.)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 15:30~15:50 EUS-Guided or Percutaneous Therapies for Cystic Liver Disease Dong Wan Seo(Univ. of Ulsan)

±³À°½Ã°£ 06¿ù 28ÀÏ ROOM 8 15:50~16:10 Surgical Treatments of Large Hepatic Cysts Seoung Yoon Rho(Yonsei Univ.)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£ÇÐȸ The Liver Week 2024 Day 2 : 2024-06-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024 ´ëÇѼö¼ú°¨¿°ÇÐȸ Çмú´ëȸ : 2024-06-29
´ÙÀ½±Û 2024 Á¦3ȸ ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ Ä¡·á½ÉÆ÷Áö¿ò : 2024-06-28
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21009 ºÎ»ê ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ºÎ»ê°æ³²Áöȸ Çмúȸ : 2024-06-25 0 4 2024-06-17
21008 °æ³² â¿ø½Ã ¼Ò¾Æû¼Ò³â°úÁöȸ ¿¬¼ö°­ÁÂ(¼Ò¾Æ ¼ÒÈ­±â Áúȯ) : 2024-06-25 0 4 2024-06-17
21007 Ãæ³² ´Ü±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ Çмúȸ(±¸°­°ÇÁ¶Áõ) : 2024-06-25 0 4 2024-06-17
21006 ¼­¿ï (¿Â¶óÀÎ) 2024³â 6¿ù ¼Ò¾Æ½ÉÃÊÀ½ÆÄ Áý´ãȸ : 2024-06-24 0 3 2024-06-17
21005 °æ±â 2024³â ¼Ò¾Æ¼ö¸é¿¬±¸È¸ Á¦2Â÷ Áý´ãȸ(¿Â¶óÀÎ) : 2024-06-24 0 2 2024-06-17
21004 Ãæ³² ´Ü±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú (¿Â¶óÀÎ) 29th Vestibular Function Test Workshop : 2024-06-23 0 3 2024-06-17
21003 ¼­¿ï ´ëÇѳëÀο©¼ºÀÇÇÐȸ Á¦33Â÷ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-06-23 0 1 2024-06-17
21002 ¼­¿ï ´ëÇÑÁ¤ÇüÅëÁõÀÇÇÐȸ - Á¦5ȸ ½ÉÈ­ ½ÉÆ÷Áö¾ö : 2024-06-23 0 2 2024-06-17
21001 ºÎ»ê ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ - Á¦19Â÷ Çмú´ëȸ : 2024-06-23 0 2 2024-06-17
21000 ¼­¿ï 2024³â 6¿ù ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ ¿¬¼ö°­Á : 2024-06-23 0 3 2024-06-17
20999 ¼­¿ï Á¦ 10ȸ ´ëÇÑ»êºÎÀΰúÃÊÀ½ÆÄÇÐȸ ¼­¿ïÁöȸ ¿¬¼ö°­Á : 2024-06-23 0 1 2024-06-17
20998 ¼­¿ï ´ëÇѵÎÅëÇÐȸ 2024³â Ãá°èÇмú´ëȸ : 2024-06-23 0 1 2024-06-17
20997 ´ë±¸ 2024³â ´ëÇѼÒÈ­±âÇÐȸ ´ë±¸°æºÏÁöȸ ¿¬¼ö°­Á : 2024-06-23 0 2 2024-06-17
20996 °æ±â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °æÀÎÁöȸ Á¦7ȸ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-23 0 10 2024-06-16
20995 ¼­¿ï Á¦18ȸ ´ëÇѺñ°úÇÐȸ ½ÉÆ÷Áö¾ö : 2024-06-23 0 8 2024-06-16
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷